Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,801 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University Montreal, Quebec, Canada
View Trial Details
Completed

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NCT02212561

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

NCT00440726

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Miller Children's Hospital Long Beach, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital & Research Center Oakland Oakland, California, United States
View all 24 locations
View Trial Details
Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01207388

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • 1102 - LKH Graz Graz, Austria
  • 1107 - Krankenhaus der Elisabethinen Linz, Austria
  • 1106 Salzburg, Austria
  • 1101 - AKH Wien Vienna, Austria
View all 75 locations
View Trial Details

Related conditions